中泰证券：政策打通手术机器人收费瓶颈 临床应用有望加速落地

Group 1 - The National Healthcare Security Administration (NHSA) has released a guideline for pricing surgical and treatment auxiliary operations, which aims to address the commercialization bottleneck of surgical robots by establishing a differentiated pricing mechanism based on clinical value and participation level [1] - The guideline categorizes pricing for robotic-assisted surgeries into three tiers: navigation, participation in execution, and precise execution, with higher fees for robots that demonstrate greater involvement and functionality [1] - The NHSA will guide local authorities in setting reasonable pricing standards to ensure clinical accessibility while enhancing pricing regulation [1] Group 2 - A new pricing item for "remote surgical assistance" has been established to facilitate the application of remote surgery, allowing medical institutions to charge for remote control of surgical instruments [2] - This pricing initiative aims to bridge the gap between clinical exploration and practical application of remote surgery, promoting the expansion of quality medical resources across regions and enhancing accessibility [2] - The introduction of remote surgery is expected to drive technological innovations in related fields, leading to advancements in surgical robots, navigation devices, and monitoring equipment [2] Group 3 - The guideline clarifies the charging policies for reusable and disposable consumables, stating that only one type of charge can be applied at a time [3] - If disposable consumables are used, they will be sold at zero markup, and no auxiliary operation fees will be charged; if reusable consumables are used, the corresponding auxiliary operation fees will be charged [3] - This regulation aims to suppress unreasonable pricing behaviors and promote more transparent clinical charging practices [3] Group 4 - The guideline includes a "data reduction" policy for medical data storage and upload, which will be part of the pricing structure [4] - Medical institutions must store and upload required medical data and device operation records; failure to do so will result in reduced charges [4] - Analyzing extensive and continuous data on device performance and clinical outcomes will help build a scientific evaluation model for efficacy and benefits, facilitating the optimization of technology applications and the development of new surgical techniques [4]